SCM
BSX icon

Sterling Capital Management’s Boston Scientific BSX Stock Holding History

Sterling Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Sell
5,862
-2,860
-33% -$155K ﹤0.01% 1159
2026
Q1 		$547K Sell
8,722
-5,559
-39% -$445K 0.01% 738
2025
Q4 		$1.36M Sell
14,281
-799
-5% -$78.3K 0.02% 542
2025
Q3 		$1.47M Sell
15,080
-1,665
-10% -$172K 0.02% 499
2025
Q2 		$1.8M Buy
16,745
+12,221
+270% +$1.24M 0.03% 423
2025
Q1 		$456K Buy
4,524
+52
+1% +$5.24K 0.01% 882
2024
Q4 		$399K Sell
4,472
-2,253
-34% -$198K 0.01% 1045
2024
Q3 		$564K Buy
+6,725
New +$530K 0.01% 798
2018
Q4 		– Sell
-254,374
Closed -$9.79M – 849
2018
Q3 		$9.79M Hold
254,374
– – 0.09% 195
2018
Q2 		$8.32M Sell
254,374
-19,847
-7% -$599K 0.08% 202
2018
Q1 		$7.49M Hold
274,221
– – 0.07% 216
2017
Q4 		$6.8M Sell
274,221
-32,428
-11% -$894K 0.06% 222
2017
Q3 		$8.95M Hold
306,649
– – 0.08% 194
2017
Q2 		$8.5M Sell
306,649
-96,416
-24% -$2.56M 0.08% 195
2017
Q1 		$10M Buy
403,065
+6,252
+2% +$152K 0.09% 182
2016
Q4 		$8.58M Sell
396,813
-21,699
-5% -$473K 0.08% 188
2016
Q3 		$9.96M Sell
418,512
-3,000
-0.7% -$71.6K 0.09% 171
2016
Q2 		$9.85M Buy
421,512
+543
+0.1% +$11.7K 0.09% 168
2016
Q1 		$7.92M Buy
420,969
+135,303
+47% +$2.38M 0.07% 190
2015
Q4 		$5.27M Buy
285,666
+101,092
+55% +$1.81M 0.05% 245
2015
Q3 		$3.03M Buy
184,574
+90,484
+96% +$1.55M 0.03% 295
2015
Q2 		$1.67M Buy
94,090
+44,090
+88% +$788K 0.02% 331
2015
Q1 		$887K Buy
+50,000
New +$790K 0.01% 479

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sterling Capital Management's BSX Position: Q2 2026 in Review

Sterling Capital Management reduced its Boston Scientific (BSX) stake by 33% in Q2 2026, selling an estimated $155K and leaving 5,862 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

Sterling Capital Management first reported a position in BSX in Q1 2015 and has held it in 23 quarters since. The position peaked at $10M in Q1 2017. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Sterling Capital Management held 5,862 shares of Boston Scientific worth $250K as of Q2 2026.
  • Sterling Capital Management sold 2,860 Boston Scientific shares in Q2 2026, an estimated $155K.
  • Boston Scientific made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1159 holding.
  • Sterling Capital Management first reported a position in Boston Scientific in Q1 2015 and has held it in 23 quarters since.
  • Sterling Capital Management's Boston Scientific position peaked at $10M in Q1 2017.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.